SG10201704812TA - Methods and compositions related to annexin 1-binding compounds - Google Patents
Methods and compositions related to annexin 1-binding compoundsInfo
- Publication number
- SG10201704812TA SG10201704812TA SG10201704812TA SG10201704812TA SG10201704812TA SG 10201704812T A SG10201704812T A SG 10201704812TA SG 10201704812T A SG10201704812T A SG 10201704812TA SG 10201704812T A SG10201704812T A SG 10201704812TA SG 10201704812T A SG10201704812T A SG 10201704812TA
- Authority
- SG
- Singapore
- Prior art keywords
- annexin
- methods
- binding compounds
- compositions related
- compositions
- Prior art date
Links
- 108090000663 Annexin A1 Proteins 0.000 title 1
- 102100040006 Annexin A1 Human genes 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28983309P | 2009-12-23 | 2009-12-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201704812TA true SG10201704812TA (en) | 2017-07-28 |
Family
ID=43923683
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012046652A SG181899A1 (en) | 2009-12-23 | 2010-12-23 | Methods and compositions related to annexin 1-binding compounds |
| SG10201704812TA SG10201704812TA (en) | 2009-12-23 | 2010-12-23 | Methods and compositions related to annexin 1-binding compounds |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012046652A SG181899A1 (en) | 2009-12-23 | 2010-12-23 | Methods and compositions related to annexin 1-binding compounds |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US9610359B2 (enExample) |
| EP (1) | EP2515944B1 (enExample) |
| JP (2) | JP6184101B2 (enExample) |
| CA (1) | CA2784645C (enExample) |
| SG (2) | SG181899A1 (enExample) |
| WO (1) | WO2011079304A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10030036B2 (en) * | 2009-05-15 | 2018-07-24 | Lahjavida, Llc | Method and dyes for detecting and destroying cancer cells |
| CN102898527B (zh) * | 2011-07-25 | 2016-12-21 | 三星电子株式会社 | 融合蛋白、药物组合物及预防或治疗癌症的方法 |
| WO2017211964A1 (en) * | 2016-06-10 | 2017-12-14 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | The core domain of annexins and uses thereof in antigen delivery and vaccination |
| CN109563128B (zh) * | 2016-08-16 | 2023-02-28 | 国立研究开发法人产业技术总合研究所 | 恶性肿瘤靶向肽 |
| US20200030452A1 (en) * | 2016-09-30 | 2020-01-30 | IF7Cure, Inc. | Process for the Manufacture of a Tumor-Vasculature Targeting Antitumor Agent |
| CN110462444A (zh) * | 2017-02-09 | 2019-11-15 | 康适智能护理系统株式会社 | 测量装置及测量探针 |
| JP6613499B2 (ja) * | 2017-08-24 | 2019-12-04 | 学校法人藤田学園 | 細胞殺傷剤 |
| KR102510514B1 (ko) * | 2018-01-09 | 2023-03-14 | 각코호진 후지타 가쿠엔 | 세포 살상제 |
| EP3796933A4 (en) * | 2018-05-17 | 2022-09-07 | Yiping Han | METHODS OF TREATMENT, PREVENTION AND DETECTION OF THE PROGNOSIS OF COLORECTAL CANCER |
| WO2019244954A1 (ja) * | 2018-06-20 | 2019-12-26 | 国立大学法人弘前大学 | ホウ素中性子捕捉療法用の腫瘍組織を短時間で選択的ないし局所的に標的化できる集積性ボロン１０薬剤 |
| JP7224628B2 (ja) * | 2019-02-01 | 2023-02-20 | 国立研究開発法人産業技術総合研究所 | 抗ｍｃ１６抗体 |
| US12109276B2 (en) | 2019-03-15 | 2024-10-08 | Lahjavida, Llc | Near-infrared dyes and conjugates for targeting tumors |
| EP3946631A1 (en) * | 2019-03-26 | 2022-02-09 | Shimadzu Corporation | Photoimmunotherapy and pharmaceutical agent used therefor |
| CN111120645B (zh) * | 2019-12-30 | 2021-10-08 | 潍柴动力股份有限公司 | 一种挡位控制方法、装置及电子设备 |
| US12370266B2 (en) | 2022-09-13 | 2025-07-29 | Core Quantum, Inc. | Polymer composite nanomaterial encapsulation system |
| CN116199748B (zh) * | 2023-01-16 | 2025-08-05 | 中国地质大学（武汉） | 多肽荧光探针及其在检测活细胞内聚集蛋白中的应用 |
| CN116606351B (zh) * | 2023-04-17 | 2025-04-18 | 合肥师范学院 | 一种基于理性分子设计构建的抗菌肽hsp-m4及制备方法和应用 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1016978B (de) | 1955-05-16 | 1957-10-03 | Iashellia Res Ltd | Mittel zur Bekaempfung des Pflanzenwachstums |
| CH588887A5 (enExample) | 1974-07-19 | 1977-06-15 | Battelle Memorial Institute | |
| JPS5186117A (en) | 1975-01-27 | 1976-07-28 | Tanabe Seiyaku Co | Johoseibiryushiseizainoseiho |
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4418052A (en) | 1980-08-12 | 1983-11-29 | Wong Dennis W | Diagnostic compositions and method for radiologic imaging of fibrinogen deposition in the body |
| US4485054A (en) | 1982-10-04 | 1984-11-27 | Lipoderm Pharmaceuticals Limited | Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV) |
| US4761288A (en) | 1984-09-24 | 1988-08-02 | Mezei Associates Limited | Multiphase liposomal drug delivery system |
| US5628936A (en) | 1987-03-13 | 1997-05-13 | Micro-Pak, Inc. | Hybrid paucilamellar lipid vesicles |
| US5474848A (en) | 1987-03-13 | 1995-12-12 | Micro-Pak, Inc. | Paucilamellar lipid vesicles |
| US4853228A (en) | 1987-07-28 | 1989-08-01 | Micro-Pak, Inc. | Method of manufacturing unilamellar lipid vesicles |
| US5011686A (en) | 1987-09-21 | 1991-04-30 | Creative Biomolecules, Inc. | Thrombus specific conjugates |
| US5013497A (en) | 1988-03-03 | 1991-05-07 | Micro-Pak, Inc. | Method and apparatus for producing lipid vesicles |
| US5024829A (en) | 1988-11-21 | 1991-06-18 | Centocor, Inc. | Method of imaging coronary thrombi |
| US5643873A (en) | 1992-05-06 | 1997-07-01 | Affymax Technologies N.V. | Peptides and compounds that bind selectins including endothelial leukocyte adhesion molecule 1 |
| AU689786B2 (en) | 1993-06-30 | 1998-04-09 | Genentech Inc. | Method for preparing liposomes |
| US6719972B1 (en) * | 1994-06-03 | 2004-04-13 | Repligen Corporation | Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA4- specific antibodies |
| US5897945A (en) | 1996-02-26 | 1999-04-27 | President And Fellows Of Harvard College | Metal oxide nanorods |
| US6506564B1 (en) | 1996-07-29 | 2003-01-14 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
| GB9708265D0 (en) | 1997-04-24 | 1997-06-18 | Nycomed Imaging As | Contrast agents |
| EP1086122B1 (en) | 1998-06-11 | 2005-08-24 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Pyrazinone protease inhibitors |
| US6451969B1 (en) * | 1999-01-15 | 2002-09-17 | The Burnham Institute | Methods for inhibiting tumor metastasis, and peptides useful therfor |
| US6716452B1 (en) * | 2000-08-22 | 2004-04-06 | New River Pharmaceuticals Inc. | Active agent delivery systems and methods for protecting and administering active agents |
| US6530944B2 (en) | 2000-02-08 | 2003-03-11 | Rice University | Optically-active nanoparticles for use in therapeutic and diagnostic methods |
| US20040037775A1 (en) * | 2000-08-01 | 2004-02-26 | Siahaan Teruna J. | Leukocyte internalized peptide-drug conjugates |
| AU2002239407B2 (en) | 2000-11-30 | 2007-12-06 | The Penn State Research Foundation | DNA methyl transferase inhibitors |
| ATE382632T1 (de) * | 2002-09-27 | 2008-01-15 | Nihon Mediphysics Co Ltd | An leukozyten bindende verbindung und diese verbindung im markierten zustand als wirkstoff enthaltende medizinische zusammensetzung |
-
2010
- 2010-12-23 JP JP2012546245A patent/JP6184101B2/ja active Active
- 2010-12-23 CA CA2784645A patent/CA2784645C/en active Active
- 2010-12-23 WO PCT/US2010/062072 patent/WO2011079304A1/en not_active Ceased
- 2010-12-23 SG SG2012046652A patent/SG181899A1/en unknown
- 2010-12-23 SG SG10201704812TA patent/SG10201704812TA/en unknown
- 2010-12-23 US US13/515,930 patent/US9610359B2/en active Active
- 2010-12-23 EP EP10803326.7A patent/EP2515944B1/en active Active
-
2015
- 2015-03-16 JP JP2015051656A patent/JP6331030B2/ja active Active
-
2017
- 2017-04-04 US US15/478,699 patent/US20170326245A1/en not_active Abandoned
-
2021
- 2021-04-26 US US17/240,714 patent/US20210260202A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013515745A (ja) | 2013-05-09 |
| US9610359B2 (en) | 2017-04-04 |
| US20210260202A1 (en) | 2021-08-26 |
| JP6184101B2 (ja) | 2017-08-23 |
| JP2015110668A (ja) | 2015-06-18 |
| SG181899A1 (en) | 2012-07-30 |
| US20120251453A1 (en) | 2012-10-04 |
| EP2515944B1 (en) | 2020-04-22 |
| CA2784645A1 (en) | 2011-06-30 |
| EP2515944A1 (en) | 2012-10-31 |
| WO2011079304A1 (en) | 2011-06-30 |
| JP6331030B2 (ja) | 2018-05-30 |
| US20170326245A1 (en) | 2017-11-16 |
| CA2784645C (en) | 2020-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201704812TA (en) | Methods and compositions related to annexin 1-binding compounds | |
| IL263729A (en) | Preparations and methods for removing biofilms | |
| HRP20181658T1 (hr) | Kruti pripravci | |
| AP3106A (en) | Antiparisitic dihydroazole compounds and compositions comprising same | |
| SI3812360T1 (sl) | Monoklorotrifluoropropenske spojine in sestavki ter postopki, ki jih uporabljajo | |
| IL222291A0 (en) | Compositions and methods of synthesis of pyridinoylpiperidine | |
| ZA201207093B (en) | Solid compositions | |
| ZA201200311B (en) | Skincare compositions | |
| GB2486127B (en) | Improved deicer composition | |
| ZA201201645B (en) | Cosmetic composition | |
| ZA201303661B (en) | Cleansing composition | |
| PL2579859T3 (pl) | Kompozycja stała zawierająca iwabradynę | |
| ZA201105384B (en) | To be advised | |
| GB0920879D0 (en) | Cosmetic composition | |
| ZA201302952B (en) | Fungicidal compositions and methods of use | |
| PL2785769T3 (pl) | Kompozycja utwardzacza epoksydowego i kompozycje od niej pochodzące | |
| GB0901494D0 (en) | Compositions and Methods | |
| GB201009275D0 (en) | Improvements in or relating to compositions | |
| GB0900582D0 (en) | Tropical composition | |
| EP2381950A4 (en) | COMPOSITIONS AND METHOD FOR THEIR USE | |
| EP2488624A4 (en) | STABILIZED SURFACTANT-OXIDANT COMPOSITIONS AND METHODS THEREOF | |
| GB201005219D0 (en) | Anti-icing compositions | |
| HK1175705A (en) | Methods and compositions related to clot-binding compounds | |
| GB201013662D0 (en) | Herbal composition | |
| GB201013661D0 (en) | Herbal composition |